about
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells.Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.Demethylation of promoter C region of estrogen receptor alpha gene is correlated with its enhanced expression in estrogen-ablation resistant MCF-7 cells.Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review).(--)-Xanthatin selectively induces GADD45γ and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells.Analysis of the relationship between diet and exercise beliefs and actual behaviors among breast cancer survivors in northwest ohioAromatase regulation and breast cancer.Letrozole for the management of breast cancer.Aromatase inhibitors in breast cancer therapy.Anti-tumor effects of letrozole.Emerging drugs for endometriosis.Novel inhibitor discovery against aromatase through virtual screening and molecular dynamic simulation: a computational approach in drug designRole of progestins with partial antiandrogenic effects.The discovery and mechanism of action of letrozole.Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.Update on the use of aromatase inhibitors in breast cancer.Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts.Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies.Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.Endocrine therapy for the treatment of postmenopausal women with breast cancer.Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cellsMolecular mechanisms of aromatase inhibition by new A, D-ring modified steroids.Synergistic cytotoxic effects of tamoxifen and black cohosh on MCF-7 and MDA-MB-231 human breast cancer cells: an in vitro study.Impairment of stimulation by estrogen of insulin-activated nitric oxide synthase in human breast cancer.Medical management of endometriosis.Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.The effect of letrozole on bone age progression, predicted adult height, and adrenal gland function.Rapid determination of anti-estrogens by gas chromatography/mass spectrometry in urine: Method validation and application to real samples.Expression of aromatase in tumor related stroma is associated with human bladder cancer progression.Current Strategies of Endocrine Therapy in Elderly Patients with Breast Cancer.Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6)
P2860
Q24813721-4CF292DA-B986-4136-9CBF-4754E7C81740Q30306356-A18DD996-881D-47AF-9F07-8CEC83F4141DQ30308047-C738F58A-21A7-4390-85BC-594DB8C30785Q30440243-5DE444F6-BD93-4F49-A2AD-91B60A6014E8Q33844198-440CC4A3-B36C-4C02-AE63-A8EDEB45C123Q33872756-230FB87C-9BC4-4C11-B1A0-C445BA854A53Q34037602-217AEABE-D3A2-48FD-AB07-1CB5BDF99E76Q34266322-9EA58AF9-D1F0-4C3E-A7E5-6CB14F152902Q34734008-9DC76472-4CB1-4220-AA7D-C19BBEBB5432Q34734521-6500E727-E5B7-45B0-894B-228019077791Q35004469-666B61AB-81AF-4B08-A6C9-A7828271C571Q35779301-3A2BA00E-DFBD-40B6-A22E-6872B9C151E3Q35937856-C4A083B2-65B7-4EAF-AF4C-0851B5F55E9BQ36019567-477F8FCA-E9BC-470E-AB25-47775A288B28Q36026408-B6A8FBC4-D08D-420A-BE82-46A5F79BAE11Q36352053-54C8C62C-4D6F-4FEC-AB9A-14F610508C32Q36613881-BEB9FEDB-7E92-4CE2-B950-EAA6C9C9D9D9Q36649092-773FBBCB-CF27-483B-9FDB-440A3E4A8796Q36675384-ED2772C5-84D6-4841-BB18-23300DEF869CQ36684234-52E0953A-276E-4CB3-B212-96FBD7454EBBQ37385376-6384446E-1FC0-4F8A-8A3F-E1971ACD6AFAQ37424009-FA525BC2-F5DB-4FED-ABAF-70CB1849DF26Q39949276-FC23E3C6-5526-4AE5-846D-599087E2AC27Q40038094-1FD4BB26-4EE5-4932-A7CD-A788EF1488C6Q42523639-88C1B2B9-A310-44AD-962B-C5CA1B68DEF5Q43267063-73F0A317-2BD6-47DE-9F84-0411F98A8DB2Q43829384-9B6CC4A5-45AE-472A-927B-DDE862FEA3FBQ46424766-CE0EC7D3-6148-4948-9E14-D0B9190E7A20Q49164218-D5271DBB-B9E6-4D5E-9350-1A4B9512C7F6Q50177196-2EA037FD-0CFA-4B95-B4C9-EE145040FCFFQ55275883-7F2AB1C2-B1CF-446C-B547-352FB4714E56Q58728345-EFB155EB-5649-4CDE-8EA0-2B37F65B65F8
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Use of aromatase inhibitors in breast carcinoma.
@ast
Use of aromatase inhibitors in breast carcinoma.
@en
type
label
Use of aromatase inhibitors in breast carcinoma.
@ast
Use of aromatase inhibitors in breast carcinoma.
@en
prefLabel
Use of aromatase inhibitors in breast carcinoma.
@ast
Use of aromatase inhibitors in breast carcinoma.
@en
P356
P1476
Use of aromatase inhibitors in breast carcinoma.
@en
P2093
H A Harvey
R J Santen
P356
10.1677/ERC.0.0060075
P577
1999-03-01T00:00:00Z